Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

被引:201
|
作者
Perrino, Cinzia
Prasad, Sathyamangla V. Naga
Mao, Lan
Noma, Takahisa
Yan, Zhen
Kim, Hyung-Suk
Smithies, Oliver
Rockman, Howard A.
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2006年 / 116卷 / 06期
关键词
D O I
10.1172/JCI25397
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered beta-adrenergic receptor (beta AR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by beta AR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
引用
收藏
页码:1547 / 1560
页数:14
相关论文
共 50 条
  • [31] Altered control of cardiac energetics in pressure overload hypertrophy
    Brandes, R
    Maier, LS
    Bers, DM
    CIRCULATION, 1997, 96 (08) : 3503 - 3503
  • [32] Autophagy and pressure overload-induced cardiac hypertrophy
    Zeng, Yong
    Ren, Wei-Qiong
    Wen, Ai-Zhen
    Zhang, Wen
    Fan, Fu-Yuan
    Chen, Ou-Ying
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2022, 24 (12) : 1101 - 1108
  • [33] Signalling pathways in pressure-overload cardiac hypertrophy
    Peivandi, A. A.
    Loeffelholz, K.
    Vahl, C. F.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2009, 23 (01): : 9 - 16
  • [34] Cytoskeletal mechanics in pressure-overload cardiac hypertrophy
    Tagawa, H
    Wang, N
    Narishige, T
    Ingber, DE
    Zile, MR
    Cooper, G
    CIRCULATION RESEARCH, 1997, 80 (02) : 281 - 289
  • [35] MECHANISM FOR CARDIAC-HYPERTROPHY BY AORTIC PRESSURE OVERLOAD
    KIRA, Y
    KOCHEL, P
    MORGAN, HE
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1257 - 1257
  • [36] Effects of enalapril in rats with pressure overload cardiac hypertrophy
    Eugenio, DD
    Pietro, G
    Rosario, M
    DeSarro, G
    GENERAL PHARMACOLOGY, 1997, 28 (04): : 531 - 533
  • [37] Kaempherol attenuated cardiac hypertrophy induced by pressure overload
    Hong, Feng
    Cao, Jianglei
    Zhang, Guangyu
    Feng, Hong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C14 - C14
  • [38] NADPH oxidase contributes to the development of contractile dysfunction during murine pressure overload cardiac hypertrophy: Pressure volume analysis of cardiac function
    Grieve, DJ
    Byrne, JA
    Layland, J
    Cave, AC
    Shah, AM
    HEART, 2004, 90 : A43 - A43
  • [39] Parkin Contributes to the Development of Cardiac Hypertrophy in Response to Cardiac Pressure Overload
    Shires, Sarah E.
    Kubli, Dieter A.
    Gonzalez, Eileen R.
    Purcell, Nicole H.
    Gustafsson, Asa B.
    CIRCULATION RESEARCH, 2015, 117
  • [40] EVOLUTION OF LEFT-VENTRICULAR DYSFUNCTION IN PRESSURE OVERLOAD HYPERTROPHY
    MIRSKY, I
    PFEFFER, J
    PFEFFER, M
    CIRCULATION, 1981, 64 (04) : 210 - 210